BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 36080280)

  • 21. [Physiology of sarcopenia. Similarities and differences with neoplasic cachexia (muscle impairments in cancer and ageing)].
    Argilés JM; Busquets S; López-Soriano FJ; Figueras M
    Nutr Hosp; 2006 May; 21 Suppl 3():38-45. PubMed ID: 16768029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanism of sarcopenia and cachexia: recent research advances.
    Sakuma K; Aoi W; Yamaguchi A
    Pflugers Arch; 2017 Jun; 469(5-6):573-591. PubMed ID: 28101649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muscle atrophy is not always sarcopenia.
    Hepple RT
    J Appl Physiol (1985); 2012 Aug; 113(4):677-9. PubMed ID: 22518833
    [No Abstract]   [Full Text] [Related]  

  • 24. Ovarian cancer ascites induces skeletal muscle wasting in vitro and reflects sarcopenia in patients.
    Ubachs J; van de Worp WRPH; Vaes RDW; Pasmans K; Langen RC; Meex RCR; van Bijnen AAJHM; Lambrechts S; Van Gorp T; Kruitwagen RFPM; Olde Damink SWM; Rensen SS
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):311-324. PubMed ID: 34951138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and Mechanisms of Skeletal Muscle Atrophy in Metabolic Conditions.
    Jun L; Robinson M; Geetha T; Broderick TL; Babu JR
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The wasting continuum in heart failure: from sarcopenia to cachexia.
    von Haehling S
    Proc Nutr Soc; 2015 Nov; 74(4):367-77. PubMed ID: 26264581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skeletal muscle wasting: the estrogen side of sexual dimorphism.
    McMillin SL; Minchew EC; Lowe DA; Spangenburg EE
    Am J Physiol Cell Physiol; 2022 Jan; 322(1):C24-C37. PubMed ID: 34788147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology of peripheral muscle wasting in cardiac cachexia.
    Filippatos GS; Anker SD; Kremastinos DT
    Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):249-54. PubMed ID: 15809526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Mechanisms of Cachexia: A Review.
    Neshan M; Tsilimigras DI; Han X; Zhu H; Pawlik TM
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fiber-Type Shifting in Sarcopenia of Old Age: Proteomic Profiling of the Contractile Apparatus of Skeletal Muscles.
    Dowling P; Gargan S; Swandulla D; Ohlendieck K
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnoliae Cortex Alleviates Muscle Wasting by Modulating M2 Macrophages in a Cisplatin-Induced Sarcopenia Mouse Model.
    Hong M; Han IH; Choi I; Cha N; Kim W; Kim SK; Bae H
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drugs of Muscle Wasting and Their Therapeutic Targets.
    Sakuma K; Yamaguchi A
    Adv Exp Med Biol; 2018; 1088():463-481. PubMed ID: 30390265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.
    Siddiqui JA; Pothuraju R; Jain M; Batra SK; Nasser MW
    Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188359. PubMed ID: 32222610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced sucrose nonfermenting AMPK-related kinase (SNARK) activity aggravates cancer-induced skeletal muscle wasting.
    Alves CRR; MacDonald TL; Nigro P; Pathak P; Hirshman MF; Goodyear LJ; Lessard SJ
    Biomed Pharmacother; 2019 Sep; 117():109197. PubMed ID: 31387190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skeletal muscle mass abnormalities are associated with survival rates of institutionalized elderly nursing home residents.
    Kimyagarov S; Klid R; Fleissig Y; Kopel B; Arad M; Adunsky A
    J Nutr Health Aging; 2012 May; 16(5):432-6. PubMed ID: 22555785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of Skeletal Muscle Atrophy in Cachexia by MicroRNAs and Long Non-coding RNAs.
    Chen R; Lei S; Jiang T; She Y; Shi H
    Front Cell Dev Biol; 2020; 8():577010. PubMed ID: 33043011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia.
    Hall DT; Ma JF; Marco SD; Gallouzi IE
    Aging (Albany NY); 2011 Aug; 3(8):702-15. PubMed ID: 21832306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscle NAD
    Hulmi JJ; Penna F; Pöllänen N; Nissinen TA; Hentilä J; Euro L; Lautaoja JH; Ballarò R; Soliymani R; Baumann M; Ritvos O; Pirinen E; Lalowski M
    Mol Metab; 2020 Nov; 41():101046. PubMed ID: 32599075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the Skeletal Muscle Proteome in Undernourished Old Rats.
    Barbé C; Salles J; Chambon C; Giraudet C; Sanchez P; Patrac V; Denis P; Boirie Y; Walrand S; Gueugneau M
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.